Latest filing published 02 Oct 2026 for Beam Therapeutics Inc., €4,026.
This profile gathers the share dealings of Bethany J. Cavanagh in Beam Therapeutics Inc. The record holds 12 filings, for trades running from 30 September 2024 to 1 October 2026.
No open-market purchase appears, only 9 sales worth €641k. Outside the open market, there are 3 share grants. So far in 2026, the count stands at no purchases and 4 sales.
Most recently, on 2 October 2026, the filings show an open-market sale worth €4,026 in Beam Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations